Teijin to integrate drug business with Kyorin

Teijin to integrate drug business with Kyorin

TOKYO, Japan - Tooru Nagashima (L), president of leading polyester maker Teijin Ltd., and Ikuo Ogihara, president of Kyorin Pharmaceutical Co., speak at a press conference at a hotel in Tokyo's Chiyoda Ward on Jan. 23. They announced that Teijin will spin off its pharmaceutical operations and integrate them with Kyorin.

  • Product Code
  • ILEA001095185
  • Registered date
  • 2003/1/23 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2003 Kyodo News
  • Media size
  • 1864 × 1713 pixel
  • Resolution
  • dpi
  • Deployment size
  • 932.50(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Beijing auto show

    Beijing auto show

    Nissan Motor Co. President Makoto Uchida (5th from L) poses for a photo during a press conference on the first day of the Beijing International Automotive Exhibition on April 25, 2024, in the Chinese capital.
      Daihatsu unveils new management policy after testing scandal

      Daihatsu unveils new management policy after testing scandal

      Daihatsu Motor Co. President Masahiro Inoue attends a press conference in Tokyo on April 8, 2024, as the company releases a new management policy following a scandal over improper safety testing. Daihatsu said its parent company Toyota Motor Corp. will be in charge of development and safety approval for some of the models Daihatsu had handled while it will focus on its mainstay minivehicle business. ==Kyodo
        Daihatsu unveils new management policy after testing scandal

        Daihatsu unveils new management policy after testing scandal

        Daihatsu Motor Co. President Masahiro Inoue attends a press conference in Tokyo on April 8, 2024, as the company releases a new management policy following a scandal over improper safety testing. Daihatsu said its parent company Toyota Motor Corp. will be in charge of development and safety approval for some of the models Daihatsu had handled while it will focus on its mainstay minivehicle business.

          Daihatsu unveils new management policy after testing scandal

          TOKYO, Japan, April 8 Kyodo - Daihatsu Motor Co. President Masahiro Inoue attends a press conference in Tokyo on April 8, 2024, as the company releases a new management policy following a scandal over improper safety testing. Daihatsu said its parent company Toyota Motor Corp. will be in charge of development and safety approval for some of the models Daihatsu had handled while it will focus on its mainstay minivehicle business. (Kyodo)
            Kobayashi Pharmaceutical dietary pills scandal

            Kobayashi Pharmaceutical dietary pills scandal

            Kobayashi Pharmaceutical Co. President Akihiro Kobayashi speaks at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.
              Kobayashi Pharmaceutical dietary pills scandal

              Kobayashi Pharmaceutical dietary pills scandal

              Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (2nd from L) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.
                Kobayashi Pharmaceutical dietary pills scandal

                Kobayashi Pharmaceutical dietary pills scandal

                Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (C) attends a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.
                  Kobayashi Pharmaceutical dietary pills scandal

                  Kobayashi Pharmaceutical dietary pills scandal

                  Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (R) apologizes at a press conference in the western Japan city of Osaka on March 29, 2024. The company said the same day it has confirmed a fifth death linked to the consumption of its red yeast rice dietary supplements and that it has yet to determine the substance that may be responsible for the deaths.
                    Keidanren chairman Tokura

                    Keidanren chairman Tokura

                    Masakazu Tokura, chairman of the Japan Business Federation, also known as Keidanren, holds a press conference in Tokyo on March 26, 2024.
                      Nissan, Honda eye EV tie-up

                      Nissan, Honda eye EV tie-up

                      Nissan Motor Co. President Makoto Uchida (L) and Honda Motor Co. President Toshihiro Mibe attend a press conference on a feasibility study by the automakers for a strategic partnership in electric vehicle production and other advanced technologies in Tokyo on March 15, 2024.